News

Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response

The foundation will provide up to $100 million to improve detection, isolation and treatment efforts; protect at-risk populations in Africa and South Asia; and accelerate the development of vaccines, drugs and diagnostics.

Read More

Feb 10, 2020

By : Team ABLE

A New Assay for Malaria Drug and Vaccine Development

The study, led by Dr. Gordon Awandare at the University of Ghana reports that Cell Trace Far-Red (CTFR), a newly developed cytoplasmic dye, can be used to study malaria parasite invasion of red blood cells.

Read More

Feb 10, 2020

By : Team ABLE

CDCSO approves mixture of anti-HIV drugs to treat nCoV patients in India

This is only for restrictive use in the interest of the public health emergency.

Read More

Feb 06, 2020

By : Team ABLE

Takeda gathers real-world evidence to demonstrate ongoing commitment in rare hematology disorders

The real-world evidence being presented by Takeda goes beyond its product portfolio and shines a spotlight on the important unmet needs faced by the wider bleeding disorders community.

Read More

Feb 06, 2020

By : Team ABLE

Eurofins acquires Gomti Life Sciences’ assets

With this acquisition, Eurofins Advinus will be able to manufacture RSMs, intermediates, APIs and NCEs.

Read More

Feb 06, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights